Posts by Joe Rojas-Burke

A better roadmap for beating a deadly leukemia

Acute myeloid leukemia, or AML, is the most common acute blood cancer in adults — and one of the most difficult to treat. Scientists at Oregon Health & Science University have discovered a...

New approach finds drug combinations to stop cancer

In the future, the most effective cancer drug therapies will likely be combinations that not only target cancer cells but also drive cancer-suppressing responses in non-cancer cells in and around...

New treatment strategy aims to stop rare liver cancer

An OHSU surgeon’s innovative approach targets deadly cholangiocarcinoma of the liver.   Jerry Widawski knew the statistics were not in his favor. At age 68, he was diagnosed with a rare...

Treatment advance for an incurable blood cancer

Researchers are reporting an impressive advance in the treatment of mantle cell lymphoma, a type of blood cancer that is considered incurable. Patients who took the drug ibrutinib in addition to a...

Progress in preventing kidney cancer recurrence

Cancer “adjuvant” therapies are treatments designed to reduce the chances of tumors coming back after surgery. But for decades, attempts to find adjuvant treatments for kidney cancer failed to...

Taking a systems approach to beating cancer

Diversity and adaptability make cancer hard to beat. To survive, tumors find many ways to cooperate with immune and other host cells, and tumors avidly split into sub-populations of cancer cells with...

Blood test could reveal transition to cancer in people at risk

Scientists have devised an accurate and sensitive way to test blood to see if a pre-cancerous condition is escalating to outright cancer — potentially enabling treatment early in tumor development...

OHSU scientists represent at AACR

A Knight Cancer Institute scientist took the reins as president of the American Association for Cancer Research. Another joined the prestigious ranks of AACR fellows. And a...

Early Detection of Cancer Conference set for Oct. 18-20

Leaders in early detection and top scientists and innovators in cancer research and bioengineering will gather in Portland, Oregon, Oct. 18-20, 2022, for the seventh in the series organized by the...

Sex hormones limit cancer immunotherapy success

Scientists have discovered how the sex hormone androgen, most commonly testosterone in men, can limit the body’s response to cancer immunotherapy, a finding that may help make those therapies more...